PER
Click for more information
1.27% 8.0¢ percheron therapeutics limited

Sarepta gene therapy study missed key target in Duchennes, page-413

  1. Akki
    35,755 Posts.
    lightbulb Created with Sketch. 554
    clock Created with Sketch.
    01/11/23
    14:02
    Post #: 70667512
    I think it's way to early to be doing that...

    I still think SRPT's drug gets passed through and opened to all ages likely before we even finish recruitment.

    If you like the idea of SRPT maybe dealing with ANP in the future it's probably best to keep it on good terms.
    Last edited by Akki: 01/11/23
    ANP Price at posting: 5.7¢ Sentiment: None Disclosure: Held
    Likes Created with Sketch. 7  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Timing will be everything for 'smashing' Hot Stock tip Judo Capital Holdings
right-arrow Created with Sketch.
EQN Equinox Resources reports outstanding naturally occurring antimony grade at Alturas Project
right-arrow Created with Sketch.
NEWS Harvey Norman may appeal ASIC Federal Court case – the third lawsuit on its plate
right-arrow Created with Sketch.
NEWS RBA holds rates as ALP election campaigning kicks off – expect more political focus
right-arrow Created with Sketch.
NEWS Update on the ASX' most anticipated drill campaign
right-arrow Created with Sketch.
NEWS PYC Therapeutics moves into final stage of child blindness study
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.0¢ 		Change
0.001(1.27%) 		Mkt cap ! $82.94M
Open High Low Value Volume
8.0¢ 8.3¢ 7.9¢ $461.5K 5.711M

Buyers (Bids)

No. Vol. Price($)
6 844186 8.0¢
 

Sellers (Offers)

Price($) Vol. No.
8.2¢ 292500 1
View Market Depth
Last trade - 16.10pm 08/11/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.